Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Short term Debt (2010 - 2018)

Updated

Sinovac Biotech (SVA) reported Short term Debt of $3.32 million for Q4 2018, down 81.7% from $18.15 million a year earlier.

Analysis

Sinovac Biotech (SVA) Short term Debt (2010 - 2018) Analysis & Trends

Dating back to Q4 2010, Sinovac Biotech's Short term Debt record includes 9 quarters.

  • Short term Debt has a five-year compound annual growth rate of -27.2% (FY2013 to FY2018).
  • By year, Short term Debt came in at $18.15 million in FY2017 (-42.0%), $31.28 million in FY2016 (+43.6%), $21.78 million in FY2015 (-54.0%) and $47.38 million in FY2014 (+192.1%).
  • The Q4 2018 figure ranks as the lowest quarterly Short term Debt in data going back to Q4 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.37 Bn 1,139.96 Bn 19.71 Bn
2 Johnson & Johnson 645.23 Bn 565.09 Bn 17.30 Bn
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn
4 Merck 361.34 Bn 315.71 Bn 12.21 Bn
5 Novartis Ag 302.82 Bn 266.81 Bn 11.24 Bn
6 Astrazeneca 267.91 Bn 241.60 Bn 12.86 Bn
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn
8 Gilead Sciences 193.55 Bn 167.74 Bn 6.22 Bn
9 Pfizer 172.05 Bn 118.70 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 3.32 Mn
Dec 31, 2017 18.15 Mn
Dec 31, 2016 31.28 Mn
Dec 31, 2015 21.78 Mn
Dec 31, 2014 47.38 Mn
Dec 31, 2013 16.22 Mn
Dec 31, 2012 3.33 Mn
Dec 31, 2011 4.71 Mn
Dec 31, 2010 10.44 Mn
API Access

Sinovac Biotech Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=SVA&period=max&api_key=YOUR_API_KEY